United States · Resolution · HRES
H.Res. 1039 (118th)
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Introduced
29 February 2024
Last action
8 March 2024 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Gottheimer, Josh [D-NJ-5], Rep. Bacon, Don [R-NE-2]
Subjects
Healthcare
Source updated
11 June 2024
Summary
This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 February 2024
Introduced
Introduced in House
Source: IntroReferral
29 February 2024
Introduced
Introduced in House
Source: IntroReferral
29 February 2024
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
8 March 2024
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 29 February 2024 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 29 February 2024
Introduced in House (PDF)
Introduced in House · EN · 29 February 2024
Introduced in House
summary · EN · 29 February 2024
Sponsors
- Rep. Gottheimer, Josh [D-NJ-5] · D · Sponsor
- Rep. Bacon, Don [R-NE-2] · R · Sponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-resolution/1039
- Open data entity: https://api.congress.gov/v3/bill/118/hres/1039
- us · 118-hres-1039 · source updated 11 June 2024